TURKISH JOURNAL OF IMMUNOLOGY, cilt.8, sa.3, ss.120-128, 2020 (ESCI)
Introduction: Ciprofloxacin (CPFX), a frequently prescribed quinolone, may induce cutaneous adverse drug reactions. Delayed type hypersensitivity reactions (DTHR) are often difficult to deal with, therefore, in vitro testing for DTHR is the long-anticipated method for their management. This study aimed to evaluate potential value of lymphocyte transformation t est (LTT) and intracellular cytokine secretion of drug srimulared CD4(+ )T cells in patients with DTHR against ciprofloxacin.